SanBio : Notice Regarding Change of Representative Director

	April 14, 2021
Company name:	SanBio Co., Ltd.
Representative:	Keita Mori, Representative Director
	and President
	(TSE Mothers Code: 4592)
Contact:	Yoshihiro Kakutani, Corporate Officer
	of Management Administration
	(TEL. [phone])

Notice Regarding Change of Representative Director

(Additional Appointment)

At a Board of Directors' meeting held on April 14, 2021, the Company resolved to approve the appointment of an additional representative director as follows.

1. Reason for change (additional appointment)

The Company decided to appoint an additional representative director and thereby adopt a three-member representative director structure to promote the development of the SanBio Group (SanBio Co., Ltd. and SanBio, Inc.) as a whole and strengthen its business structure.

2. Details of change (candidate for new representative director)

		Current position	New position
	Akihiro Tsujimura	Executive Vice President and	Representative Director,
		COO	Executive Vice President, and
			COO
＜SanBio, Inc.＞
		Current position	New position
	Akihiro Tsujimura	CEO	CEO (no change)

3. Career summary of Mr. Akihiro Tsujimura

Name		Career summary
	1992	Joined Nichimen Corp. (current Sojitz Corp.)
	2001	President & CEO, Biaxis Packaging Sales Inc., an
		overseas joint venture of Nichimen
Akihiro Tsujimura	2004	Joined Santen Pharmaceutical Co., Ltd.
(DOB: Dec. 26, 1967)	2012	Corporate Officer, Santen Pharmaceutical/ President
		& CEO, Santen Inc.
		1

	2015	Senior Corporate Officer and Head of Asia Business,
		Santen Pharmaceutical
	2016	Executive Corporate Officer and Head of Corporate
		Development Division, in charge of Asia and North
		America Businesses, Santen Pharmaceutical/ President
		& CEO, Santen Inc.
	2017	Director, Santen Pharmaceutical
	2018	Joined SanBio Co., Ltd.
		Senior Managing Executive Officer, SanBio/ CEO,
		SanBio, Inc.
	2019	Executive Officer and Senior Managing Director,
		SanBio/ CEO, SanBio, Inc.
	2020	Executive Vice President and COO, SanBio/ CEO,
		SanBio, Inc.

4. Scheduled date of change

Mr. Akihiro Tsujimura will be appointed as representative director upon approval at the Eighth General Meeting of Shareholders to be held on April 28, 2021, and will assume his post with the resolution of the Board of Directors at a meeting to be held after the conclusion of the General Meeting of Shareholders.

For details regarding the General Meeting of Shareholders, Please refer to the "Convocation Notice for the Eighth General Meeting of Shareholders" (Japanese only) published on April 13, 2021.

2